For research use only. Not for use in humans.

Domagrozumab (Anti-GDF8 / Myostatin)

Synonyms: PF-06252616 Cat.No.A2826 Purity:99%

Domagrozumab (Anti-GDF8 / Myostatin) is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab has the potential to be used in research of duchenne muscular dystrophy (DMD). MW : 143.96 KD.

Domagrozumab (Anti-GDF8 / Myostatin)

Quality Control

Batch: A282601 Purity: 99% Protein concentration: 8.86mg/ml Endotoxin Level: ＜1EU/mg

99

Mechanism of Action

Description	Domagrozumab (Anti-GDF8 / Myostatin) is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab has the potential to be used in research of duchenne muscular dystrophy (DMD). MW : 143.96 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/29121992/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1629605-31-7
Molecular Weight	143.96
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.